We now have the talk "Integrating electronic lab notebooks and knowledge management systems to accelerate discovery" delivered by Lorie Karnath, Managing Director International and Jeff Spitzner, Chief Scientific Officer, Rescentris on the KM Hub site. The problem of many different incompatibilities between data formats provides a major challenge to the pharmaceutical industry. At a time when knowledge integration and sharing, collaboration and business agility are becoming increasingly important, proprietary formats, incompatible systems and sheer data volume and complexity provide significant barriers to progress. In this Virtual Seminar we hear about the progress being made in the Life Science and bioinformatics areas so as to enable XML-based interoperability within the context of R&D and electronic laboratory notebook systems. The effort includes a new $6 million public-private partnership involving Ohio State University and Rescentris to enable greater progress in biomedical research. When I questioned Jeff Spitzner on how the significant barriers to integration over a large number of equipment and IT vendors in the bio, chemistry and medical information spaces could be overcome, he admitted that this could not be achieved in a week or even a year, but that the pharmaceutical industry should supply pressure to drive the market in this direction.
Please register at innovationwell.net to listen to the talk.
You can listen to the recorded talk at any time from any location!
Speakers
* In 1997 Jeff Spitzner received an NIH grant to develop standards for integrating and visualizing genome research data. The result was the development of BSML as the pioneering XML technology in the life sciences, and now a widely adopted XML data standard in the industry. Jeff Spitzner is recognized as a leader in areas of bioinformatics and electronic laboratory notebook systems.
* Lorie Karnath, currently runs the international operations for Rescentris and oversees the scientific advisory board, she previously served in a similar capacity for LabBook, Inc. Ms. Karnath has a background in finance and investment banking, focusing on the life sciences arena. She serves on the board of the National Foundation for Cancer Research, she is the representative for the Nobel Laureates in Lindau, and serves on a number of other boards and committees.
Seminar Summary
The goal of pharmaceutical research is to develop valuable information assets (drugs, leads, targets, diagnostics, biotechnology, new product data, etc.). The challenge for information support systems is to improve the ROI of research by accelerating the generation of these information assets and maximizing their use, value, and protection. This talk examines the needs and opportunities to integrate electronic lab notebooks (ELNs) with Pharma R&D knowledge management systems in order to help achieve these goals. The speakers discuss business, IT, regulatory, and scientific drivers of ELNs, data integration, and collaborative knowledge management, including:
· New industry initiatives for reuse, interoperability, and archiving of research data and annotations in electronic lab notebook systems
· Discover how Collaborative Research Integration goes beyond data integration to increase productivity, improve decision making, and streamline the capture and protection of intellectual property
· Examine strategies for enhancing the value of bioinformatics and clinical genomics information, including semantic integration and intelligent workflow
· Learn about approaches for using R&D data models and ontologies to integrate ELNs with enterprise KM systems and increase collaboration within and among R&D organizations
Please contact Barry Hardy, Douglas Connect, if interested in finding out more about this topic and accessing the talk.
www.douglasconnect.com
Tel : +41 61 851 0170
eFax: +44 870 112 3844
Comments